Gloria Isaza1, Sourabh Arora. 1. Division of Ophthalmology, Department of Surgery, McMaster University, Hamilton, Ont. isazazgm@mcmaster.ca
Abstract
OBJECTIVE: To analyze incidence and severity of retinopathy of prematurity (ROP) among extremely premature infants. DESIGN: Retrospective, longitudinal study. PARTICIPANTS: We studied the data concerning 207 infants whose gestational ages (GAs) were equal to 27 weeks or fewer and who were admitted to a neonatal intensive care unit between July 2006 and July 2010. METHODS: Data were extracted from the Canadian Neonatal Network, which maintains clinical information about neonates, and were confirmed by reviewing medical charts. Infants were classified into 2 groups: the GAs of the infants in group 1 were ≤ 25 weeks; those in group 2 had GAs between 26 and 27 weeks. The incidence and severity of ROP were assessed in the total screened population and between groups. RESULTS: The overall incidence of any ROP was 64.7%; 88% of infants in group 1 had any ROP compared to 48% infants in group 2. The overall incidence of type 1 ROP was 11.6%; in group 1 it was 24.4%, compared to 2.5% in group 2. Type 1 ROP was significantly associated with birth weight in grams (p < 0.001; OR = 8.20) and GA (p < 0.001; OR = 2.46). There was no difference in mean postmenstrual age at first ROP onset between group 1 and group 2 (33.5 vs 33.9 weeks, respectively). PMA at time of ROP diagnosis was not associated with development of type 1 ROP (p = 0.75; OR = 0.94; CI 0.62-1.41). CONCLUSIONS: Extremely premature infants with lower GA had a higher incidence of type 1 ROP. Earlier presentation of ROP did not predict development of type 1 ROP. No infant with a GA > 26 weeks at birth or birth weight > 1000 g had type 1 ROP.
OBJECTIVE: To analyze incidence and severity of retinopathy of prematurity (ROP) among extremely premature infants. DESIGN: Retrospective, longitudinal study. PARTICIPANTS: We studied the data concerning 207 infants whose gestational ages (GAs) were equal to 27 weeks or fewer and who were admitted to a neonatal intensive care unit between July 2006 and July 2010. METHODS: Data were extracted from the Canadian Neonatal Network, which maintains clinical information about neonates, and were confirmed by reviewing medical charts. Infants were classified into 2 groups: the GAs of the infants in group 1 were ≤ 25 weeks; those in group 2 had GAs between 26 and 27 weeks. The incidence and severity of ROP were assessed in the total screened population and between groups. RESULTS: The overall incidence of any ROP was 64.7%; 88% of infants in group 1 had any ROP compared to 48% infants in group 2. The overall incidence of type 1 ROP was 11.6%; in group 1 it was 24.4%, compared to 2.5% in group 2. Type 1 ROP was significantly associated with birth weight in grams (p < 0.001; OR = 8.20) and GA (p < 0.001; OR = 2.46). There was no difference in mean postmenstrual age at first ROP onset between group 1 and group 2 (33.5 vs 33.9 weeks, respectively). PMA at time of ROP diagnosis was not associated with development of type 1 ROP (p = 0.75; OR = 0.94; CI 0.62-1.41). CONCLUSIONS: Extremely premature infants with lower GA had a higher incidence of type 1 ROP. Earlier presentation of ROP did not predict development of type 1 ROP. No infant with a GA > 26 weeks at birth or birth weight > 1000 g had type 1 ROP.
Authors: Bayram Ali Dorum; Cansu Canbolat Yılmaz; Nilgün Köksal; Hilal Özkan; Meral Yıldız; Ahmet Tuncer Özmen Journal: Turk Pediatri Ars Date: 2017-03-01
Authors: Marie G Gantz; Waldemar A Carlo; Neil N Finer; Wade Rich; Roger G Faix; Bradley A Yoder; Michele C Walsh; Nancy S Newman; Abbott Laptook; Kurt Schibler; Abhik Das; Rosemary D Higgins Journal: Arch Dis Child Fetal Neonatal Ed Date: 2019-06-22 Impact factor: 5.747
Authors: K A Kennedy; L A Wrage; R D Higgins; N N Finer; W A Carlo; M C Walsh; A R Laptook; R G Faix; B A Yoder; K Schibler; M G Gantz; A Das; N S Newman; D L Phelps Journal: J Perinatol Date: 2014-02-06 Impact factor: 2.521
Authors: Amy K Kiefer; Joyce Y Tung; Chuong B Do; David A Hinds; Joanna L Mountain; Uta Francke; Nicholas Eriksson Journal: PLoS Genet Date: 2013-02-28 Impact factor: 5.917
Authors: Pia Lundgren; Elisabeth Stoltz Sjöström; Magnus Domellöf; Karin Källen; Gerd Holmström; Anna-Lena Hård; Lois E Smith; Chatarina Löfqvist; Ann Hellström Journal: PLoS One Date: 2013-09-12 Impact factor: 3.240